Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c

Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at Morgan Stanley

August 6, 2025 7:56 AM EDT

Morgan Stanley analyst Tejas Savant raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $11.00 (from $9.00) while maintaining a Equalweight rating.

The analyst comments "Another solid beat/raise as clonoSEQ volume/ASP momentum continues on payor traction, community/EMR uptake; MRD EBITDA... More